Trevi Therapeutics (TRVI)'s 30-day implied volatility (IV30) was 63.5% at the close on November 20, 2026, up from 54.6% the day before, against a 52-week range of 35.2% to 96.8%. Its 20-day historical volatility was 62.3%.
Data as of November 20, 2026.